Podium Abstract
Eposter Presentation
 
Accept format: PDF. The file size should not be more than 5MB
 
Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB
 
Submitted
Abstract
Predictors of Hemorrhage after Partial Nephrectomy for Stage T1 Renal Cell Carcinoma: 10-year Experience from a Regional Medical Center in Eastern China
Podium Abstract
Clinical Research
Oncology: Kidney (non-UTUC)
Author's Information
6
No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.
China
Yu Yao 962811311@qq.com The Affiliated Hospital of Qingdao University Urology Qingdao China
Junjie Ji shengshiyanjjj1314@163.com The Affiliated Hospital of Qingdao University Urology Qingdao China
Tian Liu 568523745@qq.com The Affiliated Hospital of Qingdao University Urology Qingdao China
Jingchang Mei mjc3286@163.com The Affiliated Hospital of Qingdao University Urology Qingdao China
Lijiang Sun slijiang999@126.com The Affiliated Hospital of Qingdao University Urology Qingdao China
Guiming Zhang zhangguiming9@126.com The Affiliated Hospital of Qingdao University Urology Qingdao China *
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract Content
Hemorrhage is the most frequent postoperative complication of partial nephrectomy (PN). This study aimed to develop and validate a nomogram to predict hemorrhage after PN in patients with stage T1 renal cell carcinoma (RCC).
Patients diagnosed with stage T1 RCC who underwent PN in our center over a 10-year period were retrospectively reviewed. Hemorrhage was defined as >30 g/L decrease in hemoglobin after surgery, receipt of blood transfusion, presence of arteriovenous fistula or pseudoaneurysm on imaging, or hemorrhage requiring surgical intervention. Univariate and multivariate logistic regression analyses were performed to explore potential risk factors and develop the nomogram. Internal validation was conducted to assess nomogram performance.
Among the 1015 patients included for analysis, 36 experienced hemorrhage (3.55%). Hypertension (odds ratio [OR], 2.657; 95% confidence interval [CI], 1.262–5.594, P = 0.010), tumor size (OR, 10.213; 95% CI, 3.966–26.297; P <0.001), and Mayo Adhesive Probability (MAP) score (OR, 5.158; 95% CI, 2.448–10.868; P <0.001) were independent predictors for hemorrhage and used to construct the nomogram model. The nomogram model showed a favorable predictive efficacy with area under the receiver operator characteristic curve of 0.805 (95% CI, 0.723–0.888). The corrected area under the curve was 0.799 after 1000 bootstrap resampling. The calibration curve showed its stability. Decision curve analysis and the clinical impact curve showed the nomogram’s clinical applicability in a specific threshold range.
We developed a nomogram consisting of hypertension, tumor size, and MAP score as variables to predict hemorrhage after PN in T1 stage RCC that showed high accuracy, discrimination, and stability.
hemorrhage; renal cell carcinoma; partial nephrectomy; nomogram; prediction
https://storage.unitedwebnetwork.com/files/1237/abc691195e1f383e11e6a4e2a21925b2.jpg
A nomogram for predicting hemorrhage after PN in stage T1 RCC patients, according to hypertension, tumor size, and MAP score. PN, partial nephrectomy; RCC, renal cell carcinoma; MAP, Mayo Adhesive Probability.
https://storage.unitedwebnetwork.com/files/1237/5858d513913e9487099eeafa959872c5.jpg
(a) The ROC curve for predicting hemorrhage after PN in stage T1 RCC patients. (b) Calibration curve with bootstrap method using 1,000 repetitions. ROC, receiver operating characteristic; PN, partial nephrectomy; RCC, renal cell carcinoma.
https://storage.unitedwebnetwork.com/files/1237/dee6a77c70eb9cbd68b9cddb05f9ae99.jpg
(a) Decision curve of the nomogram model. The x-axis indicates the threshold probability, and the y-axis indicates the net benefit. The grey line indicates all patients with hemorrhage and the blue line indicates no patient with hemorrhage. (b) Cli
 
 
 
 
1753
 
Presentation Details
Free Paper Podium(04): Infectious Disease / Urologic Trauma
Aug. 15 (Fri.)
14:30 - 14:36
11